Pharmacokinetic/pharmacodynamic study of monteplase ('Cleactor') in acute pulmonary embolism

Trial Profile

Pharmacokinetic/pharmacodynamic study of monteplase ('Cleactor') in acute pulmonary embolism

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Monteplase (Primary)
  • Indications Pulmonary embolism
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Jul 2008 The actual completion date for this trial is now April 2008 as reported by ClinicalTrials.gov
    • 07 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top